Centre hospitalier de Saint-Brieuc, Yves Le Foll

La Roche-sur-Yon 85925

0 studies enrolling now · 1 studies all time

What they study most

Metastatic Breast Cancer

Studies at this site

• A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer — Completed